Association between statin discontinuation after proprotein convertase subtilisin/kexin type 9 inhibitor initiation and subsequent atherosclerotic cardiovascular disease events
Post-ASCVD event rates were significantly lower in both cohorts, but discontinuation of statins was not associated with unfavorable ASCVD outcomes.
Authors
- Aryan Aiyer
- Chester B. Good (ORCID: https://orcid.org/0000-0003-4388-4558)
- Duy Ngoc (ORCID: https://orcid.org/0000-0002-7527-9320)
- Tiffany Lee (ORCID: https://orcid.org/0000-0001-5659-9831)
- Samuel K. Peasah (ORCID: https://orcid.org/0000-0002-4991-7392)
- Yan Huang (ORCID: https://orcid.org/0000-0003-1043-7604)
- Angela Inneh
- Urvashi Patel
Institutions
- UPMC Presbyterian (US)
- UPMC Center for High Value Health Care (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-03-28
- DOI
- https://doi.org/10.18553/jmcp.2025.31.4.377
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00